Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation

International Heart Journal

Volumn 51, Issue 1, 2010, Pages 34-40

  Komura, Masatoshi ^a   Suzuki, Jun Ichi ^a   Adachi, Susumu ^b   Takahashi, Atsushi ^c   Otomo, Kenichiro ^d   Nitta, Junichi ^e   Nishizaki, Mitsuhiro ^f   Obayashi, Tohru ^g   Nogami, Akihiko ^h   Satoh, Yasuhiro ⁱ   Okishige, Kaoru ^j   Hachiya, Hitoshi ^a   Hirao, Kenzo ^a   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^b Shuwa General Hospital   (Japan)

^c YOKOSUKA KYOSAI HOSPITAL   (Japan)

^d Ohme Municipal General Hospital   (Japan)

^e SAITAMA RED CROSS HOSPITAL   (Japan)

^f Yokohama Minami Kyosai Hospital   (Japan)

^g MUSASHINO RED CROSS HOSPITAL   (Japan)

^h YOKOHAMA ROSAI HOSPITAL   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

^j YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

more..

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Implantable cardioverter defibrillator; Ventricular tachycardia

Indexed keywords

AMIODARONE; APRINDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIBENZOLINE; DISOPYRAMIDE; FLECAINIDE; PIRMENOL; PROCAINAMIDE; SOTALOL; VERAPAMIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE COURSE; FEMALE; FOLLOW UP; HEART DEATH; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; JAPANESE; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE;

ADOLESCENT; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76749090030     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.34     Document Type: Article

References (22)

1. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982; 65: 384-98.
2. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-33.
3. Wichter T, Borrggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86: 29-37.
4. Klein H, Frank G, Werner PC, Borst HG, Lichtlen PR. Surgical possibilities in the treatment of ventricular tachycardia. Herz 1984; 9: 90-101. (German)
5. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000; 83: 588-95. (Review)
6. Wichter T, Paul TM, Eckardt L, et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD. Herz 2005; 30: 91-101. (Review)
7. Boriani G, Artale P, Biffi M, et al. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 2007; 22: 184-92.
8. Corrado D, Leoni L, Link MS, et al. Implantable Cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003; 108: 3048-91.
9. Tomé Esteban MT, García-Pinilla JM, McKenna WJ. Update in arrhythmogenic right ventricular cardiomyopathy: genetic, clinical presentation and risk statification. Rev Esp Cardiol 2004; 57: 757-67. (Review) (Spanish)
10. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation 2004; 110: 1879-84. (Review)
11. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71: 215-8.
12. Dalai D, Nasir K, Bomma C, et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation 2005; 112: 3823-32.
13. Hodgkinson KA, Parfrey PS. Bassett AS, et al. The impact of implantable cardioverter-difibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005; 45: 400-8.
14. Cho Y, Park T, Shin D, et al. Clinical manifestations of arrhythmogenic right ventricular cardiomyopathy in Korean patients. Int J Cardiol 2007; 122: 137-42.
15. Frigo G, Bauce B, Basso C, Nava A. Late-onset arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Med (Hagerstown) 2006; 7: 74-6.
16. Daliento L, Turrini P, Nava A, et al. Arrhythmogenic ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol 1995; 25: 655-64.
17. Basso C, Thiene G, Con-ado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 1996; 94: 983-91.
18. Roguin A, Bomma CS. Nasir K. et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004; 43: 1843-52.
19. Marchlinski FE, Zado E, Dixit S, et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 2004; 110: 2293-8.
20. Satomi K, Kurita T, Suyama K, et al. Catheter ablation of stable and unstable ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2006; 17: 469-76.
21. Dalal D. Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007; 50: 432-40.
22. Piccini JP, Dalal D, Roguin A, et al. Predictor of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2005; 2: 1188-94.